Micro RNAs as Predictive Markers in COVID-19

Grant number: P 34783

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    FWF
  • Principal Investigator

    Alice Assinger
  • Research Location

    Austria
  • Lead Research Institution

    Medical University of Vienna, Center for Physiology and Pharmacology
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

Publicationslinked via Europe PMC

Last Updated:an hour ago

View all publications at Europe PMC

Alteration of circulating ACE2-network related microRNAs in patients with COVID-19.

Editorial: Molecular drivers of immunothrombosis.

The Concept of Thromboinflammation.

Elevated plasma complement factor H related 5 protein is associated with venous thromboembolism.

Editorial: Platelet and megakaryocyte dysfunctions in infectious diseases.

Immunoglobulin G production in COVID-19 - associations with age, outcome, viral persistence, inflammation and pro-thrombotic markers.

Platelet count, temperature and pH value differentially affect hemostatic and immunomodulatory functions of platelets.

Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients : A propensity score matched analysis.

S100A8/A9 drives the formation of procoagulant platelets through GPIbα.